While both are called medullary carcinoma, these cancers differ in many ways: ...

Tubular carcinoma, treatable and slow-growing, has a good prognosis and often needs less aggressive treatment.

Breanna Bortner, from Minnesota, was previously diagnosed with stage 2B triple-negative invasive ductal carcinoma - a type of ...

Medically reviewed by Renita White, MD Cancer that develops in the ovaries (the egg-producing reproductive organs) is ...

Thymic epithelial tumors are a rare group of malignancies originating in the thymus gland, that includes thymoma and thymic ...

A research team led by Prof. SUN Cheng from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences, along with collaborators from the Agency for Science, ...

Compared with other ablative therapies, stereotactic body radiotherapy might offer a ‘particularly advantageous option’ for ...

A patient shares his experience with a squamous cell carcinoma diagnosis, treatment and recovery. It was a Friday afternoon, ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

Dr. Alan Tan explores circulating tumor DNA, its role in clinical trials and its potential impact on patients with renal cell ...